IO Biotech Inc. (IOBT) NASDAQ
$4.15 0.21 (5.33%)
Market Cap: $113.53M
As of 08/15/22 10:15 AM EDT. Market open.
IO Biotech Inc. (IOBT) NASDAQ
$4.15 0.21 (5.33%)
Market Cap: $113.53M
As of 08/15/22 10:15 AM EDT. Market open.
IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on its T-win® technology platform. The T-win® platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. IO Biotech is advancing in clinical studies its lead immuno-oncology candidate, IO102-IO103, ... read more
IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on its T-win® technology platform. The T-win® platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. IO Biotech is advancing in clinical studies its lead immuno-oncology candidate, IO102-IO103, targeting IDO and PD-L1, and through clinical and preclinical development its other pipeline candidates. IO Biotech is headquartered in Copenhagen, Denmark. read less
Open in:
Open in:
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | Nov 09, 2021 | Buy | $14.00 | 325,000 | 4,550,000 | 2,690,545 | Nov 12, 2021, 04:16 PM |
| Malier Vanessa | Director | Nov 09, 2021 | Buy | $14.00 | 325,000 | 4,550,000 | 958,559 | Nov 12, 2021, 04:16 PM |
| Vivo Capital IX, LLC | 10% Owner | Nov 09, 2021 | Buy | $14.00 | 650,000 | 9,100,000 | 3,015,545 | Nov 12, 2021, 04:16 PM |
| Andersson Claus A. | Director | Nov 09, 2021 | Buy | $14.00 | 75,000 | 1,050,000 | 1,791,490 | Nov 12, 2021, 04:16 PM |
| Lundbeckfond Invest A/S | 10% Owner | Nov 09, 2021 | Buy | $14.00 | 2,142,857 | 29,999,998 | 6,049,452 | Nov 12, 2021, 04:15 PM |
| Nielsen Jack | Director | Nov 09, 2021 | Buy | $14.00 | 650,000 | 9,100,000 | 3,015,545 | Nov 12, 2021, 04:15 PM |
| Novo Holdings A/S | 10% Owner | Nov 09, 2021 | Buy | $14.00 | 325,000 | 4,550,000 | 3,277,932 | Nov 10, 2021, 07:04 PM |
| Owner | Relationship | Date | Value($) |
| HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | 11/09/2021 | 4,550,000 |
| Malier Vanessa | Director | 11/09/2021 | 4,550,000 |
| Vivo Capital IX, LLC | 10% Owner | 11/09/2021 | 9,100,000 |
| Andersson Claus A. | Director | 11/09/2021 | 1,050,000 |
| Lundbeckfond Invest A/S | 10% Owner | 11/09/2021 | 29,999,998 |
| Nielsen Jack | Director | 11/09/2021 | 9,100,000 |
| Novo Holdings A/S | 10% Owner | 11/09/2021 | 4,550,000 |